Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia

被引:58
|
作者
Ireland, AP
Shibata, DK
Chandrasoma, P
Lord, RVN
Peters, JH
DeMeester, TR
机构
[1] Univ So Calif, Dept Surg, Sch Med, Los Angeles, CA 90033 USA
[2] Univ So Calif, Dept Pathol, Sch Med, Los Angeles, CA 90033 USA
关键词
D O I
10.1097/00000658-200002000-00005
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To compare the frequency and spectrum of p53 gene mutations in adenocarcinomas of the esophagus and cardia and to compare clinical and pathologic features in patients with p53 mutant and nonmutant cancers. Summary Background Data The p53 gene is commonly mutated in human cancers, and a p53 mutation is reported to be present in more than 50% of esophageal adenocarcinomas. Although many studies have investigated the frequency of p53 protein overexpression in adenocarcinomas of the esophagus or esophagogastric junction, few studies have assessed the frequency and clinical significance of p53 mutations in these tumors. In particular, the prognostic importance of p53 mutation is uncertain. Adenocarcinomas of the esophagus and cardia share many epidemiologic and pathologic features, but it is controversial whether they represent the same tumor. A comparison of the frequency and spectrum of mutations in adenocarcinomas of the esophagus and cardia would test whether these tumors are also similar at the molecular level. Methods DNA was isolated from microdissected paraffin-embedded tumor tissues of patients who underwent esophagogastrectomy for adenocarcinoma of the esophagus (n = 19), cardia (esophagogastric junction, n = 12), or subcardia (n = 6), Exons 5 to 8 of the p53 gene were analyzed for the presence of mutations using the polymerase chain reaction with single-strand conformation polymorphism and DNA sequencing of bands showing abnormal mobility. The presence of mutation was confirmed by selective hybridization of a mutant-specific oligonucleotide to DNA isolated from the tumor. Results p53 mutations were identified in 18 of 37 (48.6%) tumors. Patients with p53 mutant tumors were significantly younger and had a significantly poorer prognosis. There was a similar prevalence of p53 mutations in adenocarcinomas of the esophagus (53%) and cardia (58%). in contrast, mutations were relatively uncommon in subcardia adenocarcinomas (one mutant tumor [17%]). The types of mutations found in the esophageal and the cardia cancers were also similar. Conclusions Adenocarcinomas of the esophagus and cardia have a similar frequency and spectrum of p53 gene mutations, suggesting that these tumors have a common pathogenesis. Patients with mutations are younger, have signs of more advanced disease. and have a poorer prognosis than patients without mutations.
引用
收藏
页码:179 / 187
页数:9
相关论文
共 50 条
  • [31] ADENOCARCINOMA OF THE ESOPHAGUS AND OR GASTRIC CARDIA
    MACDONALD, WC
    MACDONALD, JB
    [J]. CANCER, 1987, 60 (05) : 1094 - 1098
  • [32] Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma
    Rall, CJN
    Yan, YX
    GraemeCook, F
    Beauchamp, R
    Yandell, DW
    Povoski, SP
    Rustgi, AK
    [J]. PANCREAS, 1996, 12 (01) : 10 - 17
  • [33] The clinical significance of p53 accumulation in gastric carcinoma
    Starzynska, T
    Markiewski, M
    Domagala, W
    Marlicz, K
    Mietkiewski, J
    Roberts, SA
    Stern, PL
    [J]. CANCER, 1996, 77 (10) : 2005 - 2012
  • [34] p53 mutations in oesopahgeal adenocarcinoma are common and are associated with disease response
    Oglesby, SD
    Warbrick, E
    Johnston, DA
    Dillon, JF
    Munro, AJ
    Hupp, TR
    Thompson, AM
    [J]. GUT, 2002, 50 : A92 - A92
  • [35] P53 gene mutations are associated with poor prognosis in adenocarcinoma of the lung
    Jassem, E
    Rosell, R
    Monzo, M
    De Anta, JM
    Skokowski, J
    Badzio, A
    Roszkiewicz, A
    Jassem, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S251 - S251
  • [36] P53 MUTATIONS IN BARRETTS ADENOCARCINOMA AND HIGH-GRADE DYSPLASIA
    NESHAT, K
    SANCHEZ, CA
    GALIPEAU, PC
    BLOUNT, PL
    LEVINE, DS
    JOSLYN, G
    REID, BJ
    [J]. GASTROENTEROLOGY, 1994, 106 (06) : 1589 - 1595
  • [37] P53 MUTATIONS IN BARRETTS ADENOCARCINOMA AND HIGH-GRADE DYSPLASIA
    NESHAT, K
    SANCHEZ, CA
    BLOUNT, PL
    JOSLYN, G
    REID, BJ
    [J]. CLINICAL RESEARCH, 1994, 42 (01): : A57 - A57
  • [38] PREVALENCE OF P53 MUTATIONS IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS
    GATES, CE
    REED, CE
    BROMBERG, JS
    EVERETT, ET
    BARON, PL
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 108 (01): : 148 - 152
  • [39] p53 in epidermoid cancer of the esophagus
    Tanaka, M
    Nonogaki, S
    Alberti, VN
    Forones, NM
    [J]. HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1765 - 1768
  • [40] BARRETTS-ESOPHAGUS AND P53
    LEVINE, DS
    [J]. LANCET, 1994, 344 (8917): : 212 - 213